Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · Real-Time Price · USD

19.12

-0.38 (-1.95%)

At close: Oct 10, 2025, 4:00 PM EDT

19.51

+0.39 (2.04%)

After-hours: Oct 10, 2025, 6:22 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
Microbiome Therapeutics	126.33M	Log In	Log In	Log In	Log In	Upgrade
Microbiome Therapeutics Growth	1672.24%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
United States	126.33M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	1672.24%	Log In	Log In	Log In	Log In	Upgrade